The Jammu and Kashmir administration has revised its Cancer Treatment and Management Fund for Patients scheme, increasing financial assistance for eligible families and widening the range of hospitals where beneficiaries can receive treatment.
The revised framework sets the annual family-income ceiling at Rs 4 lakh. Cancer patients from households earning up to Rs 3 lakh a year may receive assistance of Rs 75,000, while those with annual family income above Rs 3 lakh and up to Rs 4 lakh may receive Rs 50,000.
The changes are intended to reduce out-of-pocket expenditure on cancer care, including outpatient consultations, diagnostic tests and medicines. Such costs can continue over long periods and may remain substantial even when hospitalisation is covered through another health-protection programme.
Eligible beneficiaries may receive assistance under the scheme up to three times. A minimum gap of 365 days will apply between two consecutive sanctions, creating an annual cycle for repeat support while placing an overall limit on the number of claims.
Once funds are released, the concerned Deputy Commissioner will transfer the sanctioned amount directly to the beneficiary’s bank account through Direct Benefit Transfer. The revised procedure provides for the transfer to be completed within 72 hours of the release of funds.
Treatment coverage has also been expanded. Assistance may now be used at government healthcare institutions and at private hospitals empanelled under the Ayushman Bharat PM-JAY SEHAT framework. This gives eligible patients a broader choice of recognised facilities while retaining a link with an established empanelment system.
The Cancer Treatment and Management Fund is designed as targeted financial support rather than a replacement for health insurance or routine public healthcare. Its role is to help economically weaker patients meet expenses that may otherwise delay diagnosis, interrupt treatment or place additional pressure on household finances.
Cancer care commonly involves repeated investigations, medicines, follow-up visits and, depending on the case, surgery, chemotherapy or radiotherapy. The financial burden can extend beyond a single hospital admission, which makes outpatient and diagnostic coverage an important part of the revised scheme.
The income-based structure creates two levels of assistance, with the higher amount reserved for households in the lower income bracket. Applicants will still have to establish eligibility and comply with the documentation and sanction process prescribed by the administration.
Direct transfer into a verified bank account is intended to shorten the payment chain and provide a clear transaction record. The role assigned to Deputy Commissioners also places district administrations at the centre of implementation and beneficiary-level coordination.
The practical impact of the revision will depend on timely scrutiny of applications, availability of funds and awareness among patients and families. Hospitals and district authorities will have an important role in guiding eligible residents through the process and ensuring that assistance reaches them without avoidable delay.
By increasing the income limit, raising support for the lowest-income group and recognising empanelled private hospitals, the revised scheme broadens access while retaining defined eligibility and frequency limits. The changes take effect through the updated guidelines issued by the administration.
